Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion type Assertion NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_head.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion wasGeneratedBy ECO_0000203 NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_provenance.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion wasDerivedFrom befree-20140225 NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_provenance.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion SIO_000772 23738012 NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_provenance.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion evidence source_evidence_literature NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_provenance.
- NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_assertion description "[The joint effect of TERT and CLPTM1L increased risk for lung cancer with adjusted OR is 1.31(95%CI = 1.00-1.74, P = 0.052 for heterogeneity).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657086.RA_EPQbGYYgoac3n_4zu52RHxi-cYUx-hlx9Yl6bs2m1o130_provenance.